Tetracaine is an ester local anaesthetic currently available in combination with lidocaine as a cream and patch.
Ophthalmic tetracaine is indicated for the for procedures requiring a rapid and short- acting topical ophthalmic anesthetic.
The combination lidocaine and tetracaine patch is indicated for local dermal analgesia for superficial dermatological procedures and superficial venous access. The combination lidocaine and tetracaine cream is intended to provide topical local analgesia for superficial dermatological procedures.
AXIS Clinical Trials Research Center, Los Angeles, California, United States
University of Michigan Dental School, Ann Arbor, Michigan, United States
BC Women's Hospital, Vancouver, British Columbia, Canada
Big Grins, Fort Collins, Colorado, United States
Center for Dental Research Loma Linda University School, Loma Linda, California, United States
Jean Brown Research, Salt Lake City, Utah, United States
North Shore Unniversity Hospital, Manhasset, New York, United States
Center for Dental Research Loma Linda University School, Loma Linda, California, United States
University of Maryland, Baltimore, Baltimore, Maryland, United States
University of Pennsylvania, School of Dental Medicine, Philadelphia, Pennsylvania, United States
19 Locations Including, Dallas, Texas, United States
University of Buffalo, Buffalo, New York, United States
Jean Brown Research, Salt Lake City, Utah, United States
Family and Cosmetic Dentistry, Salt Lake City, Utah, United States
University of Maryland, Baltimore, Baltimore, Maryland, United States
Jean Brown Research, Salt Lake City, Utah, United States
Family and Cosmetic Dentistry, Salt Lake City, Utah, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.